Sobek Analytics

A group of 79 long term individual Celgene Corporation shareholders, collectively owning over 2,700,000 shares who are concerned with:

-          Celgene’s stagnant five year share price performance in spite of strong operational, revenue and profit growth: performance that has been accompanied by: 

-          Executive compensation criteria practices that have richly rewarded senior management executives and outside Directors.

To register our concerns with Celgene Directors by working together to:

1.       Generate the largest possible negative vote on current executive pay practices via this year’s mandatory Dodd-Frank “Say on Pay” annual shareholder meeting (ASM) proposal.

2.       To support this effort by initiating a significant grass roots shareholder letter writing campaign to current Directors, clearly stating the need for improved governance to align management and shareholder objectives by amending current “executive pay criteria” to include a significant portion of compensation to increased shareholder value, as expressed by PPS growth (at least 25%). 

To join us in contacting Directors and voting your shares “no” on the Dodd-Frank proposal.  This proposal will be listed on the proxy you will receive prior to June 2011 ASM.  We are suggesting letters to directors be sent well in advance of the annual shareholders meeting.

To provide you links to needed background information to join this effort; e.g. director contact information, current executive pay criteria, Institutional Shareholder Information, suggested Director letter content, etc.